Longeveron Inc - Class A. Every tracked FinTwit mention of $LGVN, newest first. 3 mentions since the first on Jan 7, 2026. See the price chart.
January 2026 · 3 mentions
Jan 29
Antonio Costa — $LGVN Longeveron Receives Patent From Japan Patent Office Covering Potency Assay Methods For Assessing Human Mesenchymal Stem Cells↗
Jan 26
Antonio Costa — $LGVN Longeveron Announces FDA Grants Type C Meeting Ahead of Data Readout for Pivotal Phase 2 Clinical Trial (ELPIS II) Evaluating Treatment for Hypoplastic Left Heart Syndrome (H…↗
Jan 7
Antonio Costa — $LGVN beaten down small Alzheimer name on watch. https://t.co/nwccKXy72q↗